Back to Results
First PageMeta Content
Pharmacology / Cancer vaccine / Vaccination / Ian Frazer / Calcification / Congenital heart defect / Food and Drug Administration / Regenerative medicine / Biology / Medicine / Health


Microsoft Word - AHZ150302_Heart of the matter
Add to Reading List

Document Date: 2015-03-03 10:24:46

Open Document

File Size: 296,94 KB

Share Result on Facebook

City

Perth / BRISBANE / SYDNEY / /

Company

AHZ / Merck & Co. / REGULATORY DISCLOSURES Morgans Corporate Limited / CIMB Securities Australia / Admedus Limited / MORGANS FINANCIAL LIMITED / CIMB Securities (Australia) Ltd / Minderoo Group Pty Ltd / /

Country

United States / Canada / Australia / /

Currency

AUD / USD / /

/

Event

M&A / Reorganization / FDA Phase / Company Expansion / /

IndustryTerm

or have provided banking services / platform technology / healthcare company including / medical technology / corporate finance / healthcare system / bio-manufacturing facility / manufacturing / soft tissue repair applications / /

MarketIndex

S&P/ASX 200 / /

MedicalCondition

Congenital Heart Disease / aneurysm / Co.’s highly successful cervical cancer / congenital heart defect / illness / CHD / HPV / initial infection / heart failure / infection / treating congenital heart disease / /

MedicalTreatment

soft tissue repair / surgery / immunotherapy / /

Organization

centre Number / HEAD OFFICE BRISBANE / FDA / /

Person

MILTON MT GRAVATT / Ian Frazer / REYNOLDS EQUITIES / /

/

Position

manager / clear leader / Lead Manager / co-manager / Professor / investment adviser / /

Product

CardioCel / CardioCel® patch / therapeutic vaccine / repaired using CardioCel® / CardioCel® / /

Region

SOUTH AUSTRALIA / SOUTH WALES / WESTERN AUSTRALIA / /

Technology

biomanufacturing / Biotechnology / Stem cells / tissue engineering / platform technology / Regenerative Medicine / /

URL

www.morgans.com.au/research_disclaimer / /

SocialTag